269 related articles for article (PubMed ID: 32387631)
1. Chemoprevention of keratinocyte carcinoma and actinic keratosis in solid-organ transplant recipients: Systematic review and meta-analyses.
Tee LY; Sultana R; Tam SYC; Oh CC
J Am Acad Dermatol; 2021 Feb; 84(2):528-530. PubMed ID: 32387631
[No Abstract] [Full Text] [Related]
2. Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review.
Schauder DM; Kim J; Nijhawan RI
JAMA Dermatol; 2020 Oct; 156(10):1117-1124. PubMed ID: 32639538
[TBL] [Abstract][Full Text] [Related]
3. Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients.
Allen NC; Martin AJ; Snaidr VA; Eggins R; Chong AH; Fernandéz-Peñas P; Gin D; Sidhu S; Paddon VL; Banney LA; Lim A; Upjohn E; Schaider H; Ganhewa AD; Nguyen J; McKenzie CA; Prakash S; McLean C; Lochhead A; Ibbetson J; Dettrick A; Landgren A; Allnutt KJ; Allison C; Davenport RB; Mumford BP; Wong B; Stagg B; Tedman A; Gribbin H; Edwards HA; De Rosa N; Stewart T; Doolan BJ; Kok Y; Simpson K; Low ZM; Kovitwanichkanont T; Scolyer RA; Dhillon HM; Vardy JL; Chadban SJ; Bowen DG; Chen AC; Damian DL
N Engl J Med; 2023 Mar; 388(9):804-812. PubMed ID: 36856616
[TBL] [Abstract][Full Text] [Related]
4. Declining incidence of keratinocyte carcinoma in organ transplant recipients.
Menzies S; O'Leary E; Callaghan G; Galligan M; Deady S; Gadallah B; Lenane P; Lally A; Houlihan DD; Morris PG; Sexton DJ; McCormick PA; Egan JJ; O'Neill JP; Conlon PJ; Moloney FJ
Br J Dermatol; 2019 Nov; 181(5):983-991. PubMed ID: 31049932
[TBL] [Abstract][Full Text] [Related]
5. Skin Cancer Development Is Strongly Associated with Actinic Keratosis in Solid Organ Transplant Recipients: A Danish Cohort Study.
Wenande E; Togsverd-Bo K; Hastrup A; Lei U; Philipsen PA; Haedersdal M
Dermatology; 2023; 239(3):393-402. PubMed ID: 36731451
[TBL] [Abstract][Full Text] [Related]
6. Nonmelanoma skin cancer in solid organ transplant recipients: update on epidemiology, risk factors, and management.
Tessari G; Girolomoni G
Dermatol Surg; 2012 Oct; 38(10):1622-30. PubMed ID: 22805312
[TBL] [Abstract][Full Text] [Related]
7. A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.
Chen AC; Martin AJ; Choy B; Fernández-Peñas P; Dalziell RA; McKenzie CA; Scolyer RA; Dhillon HM; Vardy JL; Kricker A; St George G; Chinniah N; Halliday GM; Damian DL
N Engl J Med; 2015 Oct; 373(17):1618-26. PubMed ID: 26488693
[TBL] [Abstract][Full Text] [Related]
8. Nicotinamide for prevention of nonmelanoma skin cancers: a change in practice?
Nestor L; Clowry J; Molloy K; Connolly M; Salim A; Tobin AM
Clin Exp Dermatol; 2017 Dec; 42(8):945-946. PubMed ID: 29044731
[No Abstract] [Full Text] [Related]
9. Keratinocyte cancer and its precursors in organ transplant patients.
Jenni D; Hofbauer GF
Curr Probl Dermatol; 2015; 46():49-57. PubMed ID: 25561206
[TBL] [Abstract][Full Text] [Related]
10. Capecitabine for skin cancer prevention in solid organ transplant recipients.
Jirakulaporn T; Endrizzi B; Lindgren B; Mathew J; Lee PK; Dudek AZ
Clin Transplant; 2011; 25(4):541-8. PubMed ID: 21050273
[TBL] [Abstract][Full Text] [Related]
11. Dermatopathology of skin cancer in solid organ transplant recipients.
Stoff B; Salisbury C; Parker D; O'Reilly Zwald F
Transplant Rev (Orlando); 2010 Oct; 24(4):172-89. PubMed ID: 20709518
[TBL] [Abstract][Full Text] [Related]
12. Actinic Keratosis in Solid Organ Transplant Recipients: A Medical Literature Review.
Morelló Vicente A; Oteiza Rius I; Aguado Gil L
Actas Dermosifiliogr; 2024 Apr; 115(4):368-373. PubMed ID: 37925069
[TBL] [Abstract][Full Text] [Related]
13. Belatacept reduces skin cancer risk in kidney transplant recipients.
Wang M; Mittal A; Colegio OR
J Am Acad Dermatol; 2020 Apr; 82(4):996-998. PubMed ID: 31589945
[No Abstract] [Full Text] [Related]
14. Nicotinamide for Skin-Cancer Chemoprevention.
Drago F; Ciccarese G; Parodi A
N Engl J Med; 2016 Feb; 374(8):789-90. PubMed ID: 26933858
[No Abstract] [Full Text] [Related]
15. Nicotinamide for Skin-Cancer Chemoprevention.
Zhao Y
N Engl J Med; 2016 Feb; 374(8):789. PubMed ID: 26933857
[No Abstract] [Full Text] [Related]
16. Nicotinamide for Skin-Cancer Chemoprevention.
Chen AC; Martin AJ; Damian DL
N Engl J Med; 2016 Feb; 374(8):790. PubMed ID: 26933856
[No Abstract] [Full Text] [Related]
17. Use of Topical and Systemic Retinoids in Solid Organ Transplant Recipients: Update and Review of the Current Literature.
Herold M; Good AJ; Nielson CB; Longo MI
Dermatol Surg; 2019 Dec; 45(12):1442-1449. PubMed ID: 31403546
[TBL] [Abstract][Full Text] [Related]
18. Overview on non-melanoma skin cancers in solid organ transplant recipients.
Forchetti G; Suppa M; Del Marmol V
G Ital Dermatol Venereol; 2014 Aug; 149(4):383-7. PubMed ID: 25068224
[TBL] [Abstract][Full Text] [Related]
19. [Not Available].
Barysch MJ
Praxis (Bern 1994); 2016 Sep; 105(18):1071-7. PubMed ID: 27606914
[No Abstract] [Full Text] [Related]
20. Nonmelanoma skin cancer in organ transplant recipients: increase without delay after transplant and subsequent acceleration.
Muehleisen B; Pazhenkottil A; French LE; Hofbauer GF
JAMA Dermatol; 2013 May; 149(5):618-20. PubMed ID: 23677099
[No Abstract] [Full Text] [Related]
[Next] [New Search]
